SCHEMBL22858711

SCHEMBL22858711

CCCN(C)C(=O)c1ccc(-c2c[nH]c3ncc(-c4cc(C)c5c(c4)CN(CCN4CCOCC4)CC5)nc23)cc1

nearest known ligand 0.83

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAP4K1 Q92918 8/20 0.83
▸ MAPK1 P28482 2/20 0.43
▸ CYP3A4 P08684 2/20 0.39
▸ JAK2 O60674 3/20 0.38
▸ JAK1 P23458 3/20 0.38
▸ TYK2 P29597 3/20 0.38
▸ JAK3 P52333 3/20 0.38
▸ GSK3B P49841 1/20 0.35
▸ CD274 Q9NZQ7 1/20 0.35
▸ CYP2C9 P11712 1/20 0.34
▸ SYK P43405 1/20 0.34
▸ KCNH2 Q12809 1/20 0.34
▸ HRH3 Q9Y5N1 1/20 0.34
▸ MAP3K11 Q16584 1/20 0.34
▸ USP2 O75604 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ CLK4 Q9HAZ1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22858703 0.91 MAP4K1 (1.00) MAP4K1MAPK1CYP3A4JAK2JAK1
SCHEMBL22858712 0.91 MAP4K1 (1.00) MAP4K1MAPK1CYP3A4JAK2JAK1
SCHEMBL29608815 0.91 MAP4K1 (1.00) MAP4K1MAPK1CYP3A4JAK2JAK1
SCHEMBL29608772 0.91 MAP4K1 (1.00) MAP4K1MAPK1CYP3A4JAK2JAK1
SCHEMBL22858702 0.91 MAP4K1 (1.00) MAP4K1MAPK1CYP3A4JAK2JAK1
SCHEMBL22858854 0.90 MAP4K1 (0.90) MAP4K1MAPK1CYP3A4JAK2JAK1
SCHEMBL22858830 0.88 MAP4K1 (0.77) MAP4K1MAPK1CYP3A4JAK2JAK1
SCHEMBL22859156 0.88 MAP4K1 (0.86) MAP4K1MAPK1CYP3A4JAK2JAK1
SCHEMBL22858924 0.88 MAP4K1 (0.77) MAP4K1MAPK1CYP3A4JAK2JAK1
SCHEMBL29609138 0.88 MAP4K1 (0.77) MAP4K1MAPK1CYP3A4JAK2JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021000925-A1 PYRROLO [2, 3-b] PYRAZINES AS HPK1 INHIBITOR AND THE USE THEREOF BEIGENE, LTD. (KY) 2021-01-07 — — WO disclosed
Send feedback